How to sharpen a novel sword from AKI basic research.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30606415.
- Also identified by DOI 10.1016/j.kint.2018.09.017.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
No specific drug against acute kidney injury is clinically available and novel findings in basic research urgently need to be translated to the clinical in order to improve the outcome of patients. Chen and colleagues demonstrated the protective role of tenascin-C on acute kidney injury by using animal models and in vitro and ex vivo experiments. We need to find a better way to overcome the barrier for translation of this new target.
Medical subject headings
- Acute Kidney Injury
- Tenascin